Newsletters

Dignitana AB Publishes May Newsletter

Dignitana AB today publishes the May 2019 edition of the company newsletter, attached to this release.

The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders. It is posted to the Dignitana website and is available by email subscription here.

Investor Relations

Melissa Bourestom, VP Marketing and Investor Relations, Dignitana  +1 469 518  5031  investorrelations@dignitana.com 

About Dignitana AB (publ)

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com.

Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00  certifiedadviser@penser.se  www.penser.se

2019-02-11

Dignitana AB today published the February 2019 edition of the company newsletter, attached to this release.

2019-01-11

Dignitana AB today published the January 2019 edition of the company newsletter, attached to this release.

2018-12-14

Dignitana AB today published the December 2018 edition of the company newsletter, attached to this release.

2018-11-02

Dignitana AB today published the November 2018 edition of the company newsletter, attached to this release.

2018-10-10

Dignitana AB today publishes the October 2018 edition of the company newsletter, attached to this release.

2018-09-07

Dignitana AB today publishes the September 2018 edition of the company newsletter, attached to this release.

2018-08-10

Dignitana AB today publishes the August 2018 edition of the company newsletter.

1
2

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90